To test our hypothesis, IHC staining of CD8, CD25, granulysin, and Foxp3 was performed for 21 cases of CTCL treated with bexarotene (Table 1). The gene discussed is FOXP3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.